AVITA Medical, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
AVITA Medical, Inc. (RCEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 60.13 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2026-02-12
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2025-12-31 was 0.00 shares.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2025-09-30 was 0.00 shares.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2024-12-31 was 0.00 shares.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2024-09-30 was 0.00 shares.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2025 was 60.13K shares, a 8.93% increase from fiscal 2024.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2024 was 55.20K shares, a 4.49% decline from fiscal 2023.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2023 was 57.80K shares, a 84.98% decline from fiscal 2022.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2022 was 384.81K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-12 | 60.13K shares 10-K · filed 2026-02-12 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 60.13K shares 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 60.13K shares 10-Q · filed 2025-08-08 | |||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | 0.00 shares derived: sum of 2 quarters · filed 2025-02-13 | 55.20K shares 10-K · filed 2025-02-13 | |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 55.20K shares 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | 55.20K shares 10-Q · filed 2024-08-08 | |||
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 0.00 shares derived: sum of 2 quarters · filed 2024-02-22 | 57.80K shares 10-K · filed 2024-02-22 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 57.80K shares 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | 57.80K shares 10-Q · filed 2023-08-10 | |||
| 2022-12-31 | 50.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 379.81K shares derived: sum of 2 quarters · filed 2023-02-23 | 384.81K shares 10-K · filed 2023-02-23 | |
| 2022-09-30 | 329.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 334.45K shares 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | 5.00K shares 10-Q · filed 2022-08-11 | |||
| 2021-12-31 | 138.73K shares derived: 10-KT 6 month − 10-Q 3 month · filed 2022-02-28 | 226.23K shares 10-KT · filed 2022-02-28 | 226.23K shares derived: sum of 3 quarters · filed 2022-02-28 | 226.23K shares derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-09-30 | 87.50K shares 10-Q · filed 2021-11-08 | 87.50K shares derived: sum of 2 quarters · filed 2021-11-08 | 87.50K shares derived: sum of 3 quarters · filed 2021-11-08 | |
| 2021-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-26 | 0.00 shares derived: sum of 2 quarters · filed 2021-08-26 | 5.00K shares 10-K · filed 2021-08-26 | |
| 2021-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | 5.00K shares 10-Q · filed 2021-05-13 | ||
| 2020-12-31 | 5.00K shares 10-Q · filed 2021-02-16 | |||
| 2020-06-30 | 444.54K shares 10-K · filed 2020-08-27 |